The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination

被引：6
|
作者：
Yang, Jingyi [1 ]
Liu, Mei-Qin [2 ]
Liu, Lin [3 ]
Li, Xian [1 ,2 ]
Xu, Mengxin [3 ]
Lin, Haofeng [2 ]
Li, Min [1 ]
Yan, Huimin [1 ]
Chen, Yao-Qing [3 ]
Shi, Zheng-Li [2 ]
机构：
[1] Fudan Univ, Translat Med Res Inst, Vaccine & Immunol Res Ctr, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China
[2] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China
[3] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen Campus, Shenzhen 518107, Guangdong, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2023年 / 8卷 / 01期
基金：
中国国家自然科学基金; 国家重点研发计划;
关键词：
D O I：
10.1038/s41392-023-01421-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
    Jingyi Yang
    Mei-Qin Liu
    Lin Liu
    Xian Li
    Mengxin Xu
    Haofeng Lin
    Min Li
    Huimin Yan
    Yao-Qing Chen
    Zheng-Li Shi
    Signal Transduction and Targeted Therapy, 8
  • [2] RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine
    Wang, Yuanyuan
    Hu, Yunqi
    Ma, Yong
    Li, Pengbin
    Zhou, Siwei
    Xu, Mengxin
    He, Bing
    Liu, Shuning
    Lv, Kexin
    Liu, Sizhe
    Zhang, Yu
    Zhou, Na
    Chen, Shifeng
    Ye, Feng
    Chen, Yao-Qing
    VACCINE, 2023, 41 (52) : 7641 - 7646
  • [3] Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
    Li, Xian
    Xu, Mengxin
    Yang, Jingyi
    Zhou, Li
    Liu, Lin
    Li, Min
    Wang, Shasha
    Liu, Mei-Qin
    Huang, Zhixiang
    Zhang, Zhen
    Liu, Shuning
    Hu, Yunqi
    Lin, Haofeng
    Liu, Bowen
    Sun, Ying
    Wu, Qingguo
    Shi, Zheng-Li
    Lan, Ke
    Chen, Yu
    Yan, Huimin
    Chen, Yao-Qing
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [4] Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
    Sun, Yi-Sheng
    Zhou, Jing-Jing
    Zhu, Han-Ping
    Xu, Fang
    Zhao, Wen-Bin
    Lu, Hang-Jing
    Wang, Zhen
    Chen, Shu-Qing
    Yao, Ping-Ping
    Jiang, Jian-Min
    Zhou, Zhan
    VIRUSES-BASEL, 2021, 13 (10):
  • [5] A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
    Tokunoh, Nagisa
    Tamiya, Shigeyuki
    Watanabe, Masato
    Okamoto, Toru
    Anindita, Jessica
    Tanaka, Hiroki
    Ono, Chikako
    Hirai, Toshiro
    Akita, Hidetaka
    Matsuura, Yoshiharu
    Yoshioka, Yasuo
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
    Zhang, Jialu
    He, Qian
    An, Chaoqiang
    Mao, Qunying
    Gao, Fan
    Bian, Lianlian
    Wu, Xing
    Wang, Qian
    Liu, Pei
    Song, Lifang
    Huo, Yaqian
    Liu, Siyuan
    Yan, Xujia
    Yang, Jinghuan
    Cui, Bopei
    Li, Changgui
    Wang, Junzhi
    Liang, Zhenglun
    Xu, Miao
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1598 - 1608
  • [7] Inactivated vaccine for SARS-CoV-2
    Emma Risson
    Nature Reviews Immunology, 2020, 20 : 353 - 353
  • [8] Inactivated vaccine for SARS-CoV-2
    Risson, Emma
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (6) : 353 - 353
  • [9] A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus
    Wang, Zhenzhen
    Li, Zhenhua
    Shi, Weiwei
    Zhu, Dashuai
    Hu, Shiqi
    Dinh, Phuong-Uyen C.
    Cheng, Ke
    SCIENCE ADVANCES, 2023, 9 (25)
  • [10] A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice
    Wang, Zhenfei
    Sun, Weiyang
    Li, Dongxu
    Sun, Yue
    Zhu, Menghan
    Wang, Wenqi
    Zhang, Yiming
    Li, Entao
    Yan, Feihu
    Wang, Tiecheng
    Feng, Na
    Yang, Songtao
    Xia, Xianzhu
    Gao, Yuwei
    VIRUS RESEARCH, 2024, 345
12345